Ex-Hedge fund manager buys rights to 62-year old drug, angers Internet mob after increasing price to $750

The drug in question is known as Daraprim and it is used to treat infants and people whose immune systems have been weakened – especially those living with AIDS.

Former hedge fund manager, Martin Shkreli

Twitter is usually such an unforgiving place but this time the ‘victim’ might actually deserve what he got.

A former hedge fund manager bought the rights to a drug that has been in use to treat parasitic infections for 62 years, then boosted the price of the drug from $13.50 per tablet to $750. And all of the Internet is after this man’s blood.

The drug in question is known as Daraprim and it is used to treat infants and people whose immune systems have been weakened – especially those living with AIDS.

It is among one of the most common treatment methods for parasitic infection that are life-threatening.

Turing Pharmaceuticals, owned by former hedge fund manager, Martin Shkriel, 32, had bought the rights to the drug and raised the price almost immediately.

See tweets of people expressing their anger at the matter:

JOIN OUR PULSE COMMUNITY!

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.com.gh